U.S. Markets close in 2 hrs 58 mins

Why Joe Biden would love to declare with Stacey Abrams as his chosen running mate

Andrew Buncombe
1 / 2
Why Joe Biden would love to declare with Stacey Abrams as his chosen running mate

Joe Biden might be about to do something unusual. So unusual, in fact, nobody can remember it ever happening before.

Reports suggest the former vice president may announce he is entering the 2020 presidential contest with a named running mate beside him. The reports suggest he would like that person to be Stacey Abrams, a progressive 45-year-old rising star within the Democratic Party, who last year narrowly failed in her bid to win the governor’s race in Georgia.

Last month, in an event that underscored the shift in the party’s direction, she was asked to deliver the Democratic response to Donald Trump’s State of the Union address.

Biden, 76, who for decades served as a senator from Delaware, has told supporters he is “95 per cent” committed to running. Even before any declaration, he heads the polls of potential Democratic candidates.

One thing that may help him seal the deal with himself, is if he gets an agreement from Abrams to be his running mate, more than a year before he would hope to secure the presidential nomination.

In what appeared to be the floating of a trial balloon, Axios recently reported Biden supporters were discussing declaring a run with Abrams as an “out-of-the-gate VP choice”, even though they recognised there was a danger it could damage the former vice president by feeding the same sort of “air of inevitability” that ultimately harmed Hillary Clinton’s 2016 run.

At the same time, the Associated Press reported Biden and Abrams met earlier this month in Washington DC – something he had requested. Abrams also had breakfast with another Democrat running for president, New York senator Kirsten Gillibrand, who tweeted a picture of the pair.

On the face of it, Biden and Abrams would be an impressive ticket, as well as a study in contrasts. He would bring experience of governance to the table, as well as an inside knowledge of the politics of Washington DC. He would also seek to appeal to white working class voters, some of whom voted for Donald Trump in 2016.

In turn, Abrams would bring energy, dynamism and be a spearhead for the progressive ideas that are now ascendant within the party. She is a woman, and a person of colour. She is from the south, he from the north.

“I think it would be a very attractive ticket,” Christina Greer, professor of politics at Fordham University in New York, told The Independent. “Some Democrats might prefer she be on the top half of the ticket, but I think even though she is a brilliant politician, it would be hard for her to go from the loss in Georgia to run for the presidency – even though we have white men doing that.”

Biden already has some standing among African Americans, especially older ones, as a result of his eight years of partnership with Barack Obama, Greer said. At the same time, during a career that included 36 years representing Delaware in the Senate, there are several incidents in his record that count against.

His apparent bullying of Anita Hill, a witness during the 1991 Clarence Thomas confirmation hearing, who accused the man about to be made a Supreme Court of sexual harassment, was one. Another was his championing of a 1994 crime bill – “the toughest, most comprehensive crime bill in our history” according to him – which disproportionately impacted minority offenders.

Abrams has avoided commenting on the prospect of joining Biden, as he embarks on what would be his third run for the Oval Office. She told the AP she had not yet decided whether to challenge Republican David Perdue for the Senate seat from Georgia that will be contested in 2020.

“There certainly is a connectivity between that and other 2020 opportunities,” she said. “My objective is to make sure I want to do that job. I’d not thought about the Senate before. The Senate is a different way to tackle the issues I see.”

After Democrats last autumn regained control of the House of Representatives on the backs of women voters, and with four high profile women – Elizabeth Warren, Gillibrand, Kamala Harris and Amy Klobuchar – already running, Biden is not the only person who sees the value of having a woman VP.

The New York Times said New Jersey senator Cory Booker had claimed a woman would be on the Democratic ticket, whether alongside him or someone else.

“No matter what – I’m looking you in the eye and saying this – there will be a woman on the ticket,” he said. “I don’t know if it’s in the vice president’s position or the president’s position, but if I have my way, there will be a woman on the ticket.”

Texas congressman Beto O’Rourke made a similar undertaking to an audience in Iowa.

“It would be very difficult not to select a woman, with so many extraordinary women who are running right now,” he said. “First, I would have to win, and this is as open as it’s ever been.”

Mike Fraioli, a veteran Democratic strategist and fundraiser based in Washington DC, said if Biden declared with a named running mate he could think of no precedent.

The only similar situation came in April 2016 – late in the Republican primary contest – when senator Ted Cruz named businesswoman Carly Fiorina as his theoretical VP pick. He did so in a last ditch effort to inject energy into his flailing campaign. A week later, he pulled out, ceding the field to Trump.

Fraioli said the strategising of Biden, Booker and O’Rourke marked an important inflection point.

“It shows the country has changed,” he said. “For the Democrats, a woman or a person of colour will fill one of the top two spots. It’s not going to be two white guys. That’s not happening. That’s gone.”

  • Here's the next disaster in retail. Hint: it's not J.C. Penney dying
    Business
    Yahoo Finance

    Here's the next disaster in retail. Hint: it's not J.C. Penney dying

    Thanks to shoppers spending cautiously on clothes in recent months — despite a rallying stock market and low 3.7% unemployment rate — retailers of all kinds are sitting on mountains of excess inventory. Now that inventory must be worked off at profit-margin-busting prices in order to make way for the lucrative, full-price garb targeted to back to school shoppers in August and September. That backdrop sets the stage for scores of earnings misses, lowered profit outlooks and downtrodden earnings calls with Wall Street when the retail sector begins to release results in mid-August.

  • Do the math. Here's why you shouldn't claim Social Security at 62
    News
    USA TODAY

    Do the math. Here's why you shouldn't claim Social Security at 62

    Many would-be beneficiaries use a break-even analysis which, in essence, tells them the age (or ages) when it makes the most financial sense to claim benefits. Using this sort of analysis can be helpful. But experts say it shouldn't be the only factor you consider when deciding when to apply for Social Security. You start the analysis by calculating what your cumulative benefits would be based on the age you apply for Social Security.

  • Trump’s stock market still lags Obama’s, but that could be about to change
    Business
    MarketWatch

    Trump’s stock market still lags Obama’s, but that could be about to change

    Donald Trump loves telling us all about how fantastic the stock market has done under his leadership. McBride, for his part, says he doesn't believe the market is a great measure of policy performance, but he acknowledges that some, including Treasury Secretary Steven Mnuchin, do. “My view is there are many measures of success — and that the economy needs to work well for a majority of the people — not just stock investors,” McBride explained in a “just for fun” blog post over the weekend.

  • Is Johnson & Johnson a Buy?
    Business
    Motley Fool

    Is Johnson & Johnson a Buy?

    All of this might make you think that Johnson & Johnson is a stock to avoid. But is it actually a smart pick for long-term investors to buy now? Here are the arguments for and against J&J. Reasons to buy One of the biggest attractions for Johnson & Johnson is its dividend.

  • Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect
    Business
    MarketWatch

    Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect

    Bristol-Myers, scheduled to announce second-quarter results on Thursday before the market opens, is expected to report earnings of $1.07 a share, up from $1.01 a share in the year-earlier quarter. Analysts polled by FactSet expect sales to rise to $6.109 billion from $5.704 billion a year ago, with the company's best-selling drug Eliquis expected to contribute $1.972 billion compared with $1.650 billion a year ago. Sales of Opdivo, another blockbuster drug, should rise to $1.815 billion from $1.627 billion a year ago.

  • Where Will Sirius-XM Holdings Be in 5 Years?
    Business
    Motley Fool

    Where Will Sirius-XM Holdings Be in 5 Years?

    Satellite radio has never as popular as it is right now, but Sirius XM Holdings (NASDAQ: SIRI) investors aren't feeling the love. Growth is slowing, and it's fair for investors to question if satellite radio will be as ubiquitous in the future as it is today. Sirius XM has lived and died by its premium radio service that is consumed primarily by drivers.

  • Vail Resorts set to acquire operator of 17 U.S. ski areas in $264M deal
    Business
    American City Business Journals

    Vail Resorts set to acquire operator of 17 U.S. ski areas in $264M deal

    Broomfield-based Vail Resorts Inc. NYSE: MTN) announced Monday morning that it is acquiring Peak Resorts Inc. Nasdaq: SKIS) in a deal valued at $264 million.

  • Israel Begins Demolishing Palestinian Homes in East Jerusalem
    World
    Meredith Videos

    Israel Begins Demolishing Palestinian Homes in East Jerusalem

    Israeli work crews on Monday began demolishing dozens of Palestinian homes in an east Jerusalem neighborhood, in one of the largest operations of its kind in years.

  • Amarin: Is a Buyout Really Off the Table?
    Business
    Motley Fool

    Amarin: Is a Buyout Really Off the Table?

    Amarin (NASDAQ: AMRN) drew the ire of its shareholders last week by rolling out a breathtaking $460 million capital raise. First up, the biopharma recently announced that sales of its prescription omega-3 treatment, Vascepa, have been going strong ever since the drug showed a 25% relative risk reduction in terms of serious cardiovascular events in the outcomes trial known as Reduce-It. Amarin, in turn, reported that its cash position stood at a healthy $221 million at the end of June, thanks to Vascepa's strong sales trajectory.

  • Business
    MarketWatch

    Applied Materials, Lam Research stocks rise after Goldman turns bullish

    Goldman Sachs analyst Toshiya Hari upgraded Applied Materials Inc. (amat) and Lam Research Corp. (lrcx) shares to buy from neutral on Monday, while also upgrading KLA Corp. shares (klac) to neutral from sell. Applied's shares have risen 46% so far this year, as the S&P 500 (spx) has gained 19%.

  • The Absurdity of Aurora Cannabis' Latest Analyst Downgrade
    Business
    Motley Fool

    The Absurdity of Aurora Cannabis' Latest Analyst Downgrade

    But Carey recently downgraded Aurora to neutral only three months after initiating coverage on the stock with a buy recommendation. Wall Street analysts change their views on stocks all of the time, of course. But this latest downgrade for Aurora illustrates the absurdity of giving too much weight to analysts' recommendations.

  • 3 Terrible Reasons to Sell Canopy Growth
    Business
    Motley Fool

    3 Terrible Reasons to Sell Canopy Growth

    Canopy Growth (NYSE: CGC) quickly went from being a favorite cannabis stock for many investors to a favorite stock to bash. With Canopy Growth founder and longtime CEO Bruce Linton getting pushed out earlier this month, some investors are probably wondering if it's time to throw in the towel on the stock. Sure, Canopy Growth's share price has plunged nearly 30% since the beginning of May. But selling because of this drop is one of the worst reasons you could possibly come up with.

  • Icahn Slams Occidental's Anadarko Deal in Quest to Win Four Board Seats
    Business
    Bloomberg

    Icahn Slams Occidental's Anadarko Deal in Quest to Win Four Board Seats

    Activist investor Carl Icahn has accused Occidental Petroleum Corp.'s leaders of putting together the $38 billion deal for Anadarko Petroleum Corp. in a bid to stave off its own potential takeover. Bloomberg's Scott Deveau reports on "Bloomberg Markets."

  • A Foolish Take: Netflix's Pricing Power Hits a Wall
    News
    Motley Fool

    A Foolish Take: Netflix's Pricing Power Hits a Wall

    Netflix's (NASDAQ: NFLX) stock recently tumbled after its global subscribers rose just 2.7 million to 151.56 million in the second quarter, missing its guidance for 5 million new subscribers. Subscribers in its core U.S. market declined by 130,000 to 60.1 million. Netflix attributed that soft growth to price hikes.

  • Wanna Bet $1.3 Trillion on Chinese Regulators?
    Business
    Bloomberg

    Wanna Bet $1.3 Trillion on Chinese Regulators?

    In fact, the country's largest search and e-commerce provider(1)is ultimately controlled by Alibaba Partnership, a collection of 38 people, most of whom hold senior positions in the company. This business structure, called a variable-interest entity, became common among Chinese companies because Beijing restricts foreign investment in certain sectors, such as the internet. It also enables firms to raise money abroad and lets early investors get their funds out of the country. Tencent Holdings Ltd., Meituan Dianping and Baidu Inc. all hew to various versions of the VIE, allowing them to exploit a gap in Chinese law.

  • Apple stock leads Dow higher after Morgan Stanley cites ‘attractive’ earnings setup
    Business
    MarketWatch

    Apple stock leads Dow higher after Morgan Stanley cites ‘attractive’ earnings setup

    Apple Inc. shares are rising in Monday trading after an analyst at Morgan Stanley praised the “attractive” setup heading into the company's earnings report next Tuesday. Morgan Stanley's Katy Huberty raised her price target on Apple's stock (AAPL)to $247 from $231, writing that the smartphone giant faces only a “low risk” of disappointing with its September outlook given a low bar on Wall Street. “Investor sentiment remains negative despite improving iPhone and services data points,” Huberty said in her note to clients.

  • Why Dillard's, Inc.’s (NYSE:DDS) Return On Capital Employed Looks Uninspiring
    Business
    Simply Wall St.

    Why Dillard's, Inc.’s (NYSE:DDS) Return On Capital Employed Looks Uninspiring

    Today we are going to look at Dillard's, Inc. (NYSE:DDS) to see whether it might be an attractive investment prospect. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. Firstly, we'll go over how we calculate ROCE.

  • Business
    MarketWatch

    Tesla stock downgraded to hold at Roth Capital

    Analyst Craig Irwin at Roth Capital Partners on Monday downgraded Tesla Inc. (tsla) stock to their equivalent of hold, from buy, saying he sees the shares' risk-reward equation "as well balanced at current levels." Tesla has a "viable path tfor meeting at least the low end" of its guidance to deliver between 360,000 and 400,000 cars this year, he said. Tesla is scheduled to report second-quarter results on Wednesday. The stock is down 22% this year, contrasting with gains of 19% and 16% for the S&P 500 index (spx) and the Dow Jones Industrial Average.

  • Business
    TheStreet.com

    Lennox Falls After Second-Quarter-Earnings Miss, Lower Guidance

    Shares of Lennox International dropped on Monday after the Dallas provider of commercial and residential heating and cooling equipment missed analysts' estimates for second-quarter earnings and sales. A survey of analysts by FactSet produced consensus estimates of profit of $4.12 a share on sales of $1.15 billion. Lennox Chairman and CEO Todd Bluedorn said in a statement that the results reflected cooler temperatures and higher precipitation across the U.S., particularly in key central regions.

  • Introducing Himax Technologies (NASDAQ:HIMX), The Stock That Slid 67% In The Last Three Years
    Business
    Simply Wall St.

    Introducing Himax Technologies (NASDAQ:HIMX), The Stock That Slid 67% In The Last Three Years

    Unfortunately, they have held through a 67% decline in the share price in that time. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). In this case, it seems that the EPS is guiding the share price.

  • Should Investors Worry About J.C. Penney's Debt?
    Business
    Motley Fool

    Should Investors Worry About J.C. Penney's Debt?

    J.C. Penney's (NYSE: JCP) stock recently stumbled after Reuters claimed that the retailer "hired advisors to explore debt restructuring options." The report, which cited people "familiar with the matter," called the move a "high-stakes attempt to get its financial house in order" before its debt of nearly $4 billion matures within the next few years. J.C. Penney issued a press release to counter Reuters' report, stating that its liquidity was strong, that it had "no significant debt maturities coming due in the near term," and that it hadn't hired any advisors for an "in-court restructuring or bankruptcy."

  • Sen. Elizabeth Warren says ‘warning lights are flashing,’ cautions that ‘odds of another economic downturn are high’
    Politics
    MarketWatch

    Sen. Elizabeth Warren says ‘warning lights are flashing,’ cautions that ‘odds of another economic downturn are high’

    As Warren describes it, those risk factors include, mounting household debt, with student loan debt more than doubling since the 2008 financial crisis (New York Times paywall), and a recession in manufacturing, which many industry officials have said has been exacerbated by the China-U.S. trade war that has lasted more than year and has been a key catalyst in the Federal Reserve's inclination to reduce corporate borrowing costs at the conclusion of its two-day policy gathering on July 31.

  • Business
    MarketWatch

    Micron stock gains after Goldman upgrade

    Shares of Micron Technology Inc. (mu) are up 2.7% in premarket trading Monday after Goldman Sachs analyst Mark Delaney upgraded the stock to buy from neutral, reflecting his growing optimism on memory stocks and his view that companies with excess inventory will be able to deplete their inventory more quickly than anticipated. "We believe that Micron is the best stock to express our view," he wrote. "Importantly, we believe that Micron's stock will trade more on memory pricing trends and intermediate term EPS expectations than FY20 earnings." Delaney is skeptical that Chinese companies will be able to enter the DRAM market in the next few years given their limited progress in the area thus far.

  • Snap earnings: With stock up more than 170%, investors looking for turnaround
    Business
    MarketWatch

    Snap earnings: With stock up more than 170%, investors looking for turnaround

    Snap Inc. shares have soared this year on expectations that the company is finally turning its business around, and the Snapchat maker will be looking to prove that narrative next Tuesday when it reports second-quarter earnings after the closing bell. Stock movement: Snap shares have only posted gains following two of the company's nine earnings reports since it went public. Snap has finally updated its Android app and introduced new buzz-worthy features, developments that are expected to have drawn more users to the Snapchat app in recent months.

  • 2 Penny Stock Marijuana Plays That Could Make You Rich
    Business
    Motley Fool

    2 Penny Stock Marijuana Plays That Could Make You Rich

    That being said, there are some potential diamonds in the rough bumping around the penny cannabis stock landscape right now. For example, Aleafia Health (NASDAQOTH: ALEAF) and MedMen Enterprises (NASDAQOTH: MMNFF) both sport intriguing risk-to-reward ratios, despite their exceptionally low price per share. Here's a brief overview of the potential risks and rewards associated with these two penny pot stocks.